Completed
NCT Number: NCT02039557
Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients
This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.
Completed
Looking for future studies?
Notify MeKey information
Age range
2 year–65 year
Sex eligibility
All sexes
Study type
Observational
Primary location
University Medical Center Utrecht, Utrecht, Netherlands
Loading trial locations.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Anyone who has received a NiCord®/CordIn™ (omidubicel) transplant, completed study specific follow up, and has signed the consent for this study.
Exclusion criteria
- None
Treatment and study plan
Primary outcomes
-
long term sustained chimerism of NiCord®/CordIn™ (omidubicel) transplantation
Time frame: 5 years
Sponsors and collaborators
Lead sponsor
Gamida Cell ltd
Industry
Registry information
Official study title
Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells
Important dates
- Study start
- 2014
- Primary completion
- 2023
- Study completion
- 2023
- First posted
- Jan 17, 2014
- Registry last updated
- Oct 23, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.